Register Login

Syndax Pharmaceuticals Inc (SNDX)

  • Event
  • June 13, 2022, 11:32 UTC

(10% Negative) SYNDAX PHARMACEUTICALS, INC. (SNDX) Announces Delay in time Trials for areas of clear unmet need Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

Full text
Register to leave comments
  • News bot Oct. 2, 2025, 6:35 a.m.

    📋 SYNDAX PHARMACEUTICALS, INC. (SNDX) - Clinical Trial Update

    Filing Date: 2022-06-13

    Accepted: 2022-06-13 07:32:20

    Event Type: Clinical Trial Update

    Event Details:

    Syndax Pharmaceuticals Inc (SNDX) Announces Clinical Trial Update Syndax Pharmaceuticals Inc (SNDX) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: time, year
    • Diseases/Conditions: areas of clear unmet need
    • Update Type: Trial Timeline Adjustment
    • Primary Factors: Pandemic-Related Challenges, Patient Enrollment, Regulatory Process
    • Collaboration: Syndax Pharmaceuticals, Inc.

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval: Not available
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Syndax Pharmaceuticals Inc
    • CIK: 0001395937
    • Ticker Symbol: SNDX
    • Period End Date: 2022-06-08
    • Document Type: 8-K

Search

News categories